Feiteng Qi, Qi Sun, Haifeng Wang, Yong Zhang. Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report. // BMC Neurology. – 2025. – DOI: 10.1186/s12883-025-04288-0. – URL: https://doi.org/10.1186/s12883-025-04288-0
Feiteng Qi, Qi Sun, Haifeng Wang, & Yong Zhang (2025). Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report. BMC Neurology. https://doi.org/10.1186/s12883-025-04288-0
Feiteng Qi, et al. “Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report.” BMC Neurology, 2025. doi:10.1186/s12883-025-04288-0.
@article{Qi2025,
title = {Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report},
author = {Qi, Feiteng and Sun, Qi and Wang, Haifeng and Zhang, Yong},
journal = {BMC Neurology},
year = {2025},
doi = {10.1186/s12883-025-04288-0},
url = {https://doi.org/10.1186/s12883-025-04288-0}
}